비교리스트

 카트 문의
시장보고서
상품코드
1335278

세계의 캐리어 스크리닝 시장 : 유형별, 질환별, 기술별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Carrier Screening Market with COVID-19 Impact Analysis, By Type, By Medical Condition, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 354 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 캐리어 스크리닝 시장 규모는 2022년 21억 680만 달러로 2023년부터 2030년까지 14.8%의 CAGR로 확대될 것으로 예상됩니다.

캐리어 스크리닝 시장 - 시장 역학

  • 질병 조기 발견에 대한 관심 증가로 시장 성장 촉진
  • 질병의 조기 발견 및 예방에 대한 중요성이 높아지고 유전성 질환에 대한 선별 검사 이용이 증가하는 것은 캐리어 스크리닝 시장 확대의 주요 요인이며, 예측 기간 동안 이 두 가지가 모두 발생할 것으로 예상됩니다. 예를 들어, 2022년 5월에 업데이트된 미국 질병예방통제센터(CDC) 자료에 따르면, 겸상적혈구증은 전 세계적으로 수백만 명이 앓고 있으며, 특히 사하라 사막 이남의 아프리카, 남미, 카리브해, 중미 등 스페인어권, 사우디아라비아, 인도, 지중해 연안 국가를 조상으로 둔 사람들 사이에서 유행하고 있습니다.

캐리어 스크리닝 시장 - 세분화 분석

  • 세계 캐리어 스크리닝 시장은 유형, 병리, 기술, 최종사용자 및 지역을 기준으로 세분화됩니다.
  • 유형에 따라 시장은 확장된 캐리어 스크리닝과 대상 질환 캐리어 스크리닝으로 나뉩니다. 확장된 캐리어 스크리닝 분야는 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다. 인종적 기원과 무관하게 다양한 유전적 질환을 검사하는 ECS가 캐리어 스크리닝의 한 유형으로 부상하고 있습니다. 시장 점유율을 확대하기 위해 기업들은 제품 개발과 같은 전략적 활동을 하고 있습니다. 예를 들어, 미테라(Mitera)는 2022년 1월 미국에서 두 가지 유전자 검사 제품을 출시할 것이라고 발표했는데, 그 중 하나는 421개의 유전 질환 중 하나의 위험을 평가하는 데 도움이 되는 가정용 확장형 캐리어 스크리닝 검사입니다. 이는 고객에게 제품의 접근성과 편의성을 향상시켜 예측 기간 동안 이 분야의 성장을 촉진할 것입니다.

캐리어 스크리닝 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역은 비지니스를 가져오는 국가에 따라 더 세분화됩니다. 예측 기간 동안 북미가 시장을 지배할 것으로 예상됩니다. 북미 시장 확대는 미국 식품의약국(FDA)의 제품 승인 증가와 후속 출시, 혁신적인 유전자 검사 제품 발명을 위한 연구 활동에 종사하는 주요 기업의 집중에 의해 촉진될 것으로 예상됩니다. 예를 들어, 미테라(Mitera)는 2022년 1월에 Peaches &Me와 23Pears의 가정용 생식 유전자 검사 키트를 50개 주에서 사용할 수 있게 될 것이라고 선언했습니다. Peaches & Me는 고객이 온라인에서 구입하여 집에서 시행할 수 있는 최초의 비침습적 산전검사(NIPT)입니다. 이 검사는 임신 10주부터 아기의 성별을 확인하고 다운증후군과 같은 질병을 선별할 수 있습니다. 따라서 예측 기간 동안 이 제품이 시장을 장악할 것으로 예상됩니다.

캐리어 스크리닝 시장 - 경쟁 상황

세계 캐리어 스크리닝 시장의 주요 기업들은 제품 라인업을 다양화하기 위해 연구 개발 노력을 강화하고 있습니다. 또한, 이러한 시장 진입 기업들은 성장을 촉진하기 위해 전략적 제휴 및 파트너십을 활용하고 있습니다. Myriad Genetics, Inc., Cepheid, Illumina, Thermo Fisher Scientific Inc, F.Hoffmann - La Roche Ltd. America Holdings, Otogenetics, MedGenome, GeneTech, Centogene N.V. 등이 있습니다.

목차

제1장 캐리어 스크리닝 시장 개요

  • 조사 범위
  • 시장 추정 연수

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 캐리어 스크리닝 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 캐리어 스크리닝 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 캐리어 스크리닝 시장 : COVID-19의 영향 분석

  • 신종 코로나바이러스 감염증 이전의 영향 분석
  • 신종 코로나바이러스 감염증 후의 영향 분석

제6장 캐리어 스크리닝 시장 상황

  • 캐리어 스크리닝 시장 점유율 분석, 2022년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 캐리어 스크리닝 시장 - 유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 캐리어 스크리닝 확대
    • 표적 질환 캐리어 스크리닝

제8장 캐리어 스크리닝 시장 - 병상별

  • 개요
    • 병상별 부문 점유율 분석
    • 낭포성섬유증
    • 테이삭스병
    • 고셔병
    • 겸상적혈구증
    • 척수성 근위축증
    • 기타

제9장 캐리어 스크리닝 시장 - 기술별

  • 개요
    • 부문 점유율 분석(기술별)
    • DNA 배열 결정
    • 중합효소 연쇄 반응
    • 마이크로어레이
    • 기타

제10장 캐리어 스크리닝 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원
    • 연구실
    • 진료소·클리닉
    • 기타

제11장 캐리어 스크리닝 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 캐리어 스크리닝 업계

  • 경쟁 대시보드
  • 기업 개요
    • Thermo Fisher Scientific Inc
    • Cepheid
    • Illumina
    • Myriad Genetics, Inc
    • F.Hoffmann - La Roche Ltd
    • Laboratory Corporation of America Holdings
    • Otogenetics
    • MedGenome
    • GeneTech
    • Centogene NV

제13장 애널리스트의 전방위 전망

ksm 23.10.25

REPORT HIGHLIGHT

Carrier Screening Market size was valued at USD 2,106.8 Million in 2022, expanding at a CAGR of 14.8% from 2023 to 2030.

Carrier screening is a genetic testing method used to find abnormal genes that might lead to autosomal recessive diseases in fetuses. Pregnant people and couples can examine the likelihood that their unborn child will inherit genetic diseases from one or both of their parents using this predictive and presymptomatic testing method. For diseases including cystic fibrosis, sickle cell anemia, and Tay-Sachs disease, it entails analyzing a sample of saliva, blood, or cheek tissue to look for the presence of an abnormal gene.

Carrier Screening Market- Market Dynamics:

  • Increasing emphasis on early disease detection to propel market growth.
  • The expanding emphasis on early disease identification and prevention as well as the rising use of screening tests for genetic diseases are key drivers of the carrier screening market expansion, both of which are anticipated to occur throughout the forecast period. For instance, according to data from the Centers for Disease Control and Prevention (CDC) updated in May 2022, sickle cell disease affects millions of people worldwide and is especially prevalent among people whose ancestors originated from sub-Saharan Africa, Spanish-speaking areas like South America, the Caribbean, and Central America, as well as Saudi Arabia, India, and Mediterranean nations.

Carrier Screening Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Carrier Screening market is estimated to grow annually at a CAGR of around 14.8% over the forecast period (2023-2030)
  • The Carrier Screening industry is projected to grow at a significant rate owing to the rise in funding by the government and private sector
  • Based on type segmentation, the Expanded Carrier Screening segment is expected to grow at the fastest rate over the forecast period
  • Based on region, North America is expected to dominate the market over the forecast period

Carrier Screening Market- Segmentation Analysis:

  • The Global Carrier Screening Market is segmented based on type, medical condition, technology, end user, and Region.
  • Based on type, the market is bifurcated into Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening segment is expected to grow at the fastest rate over the forecast period. The ECS, which screens for a wide range of genetic illnesses independent of ethnic origin, is the rising carrier screening type. To increase their market share, businesses are engaging in strategic activities like product creation. For instance, Mitera stated in January 2022 that it will introduce two genetic test products in the United States, one of which was an at-home extended carrier screening test that helps people assess their risk of any of 421 genetic illnesses. For customers, this improves product accessibility and convenience. Thereby, driving the segment growth over the forecast period.

Carrier Screening Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. It is predicted that market expansion in North America would be fueled by rising product approvals by the US Food and Drug Administration (FDA) and subsequent launches, as well as the high concentration of major firms engaged in research activities for the invention of innovative genetic testing products. For instance, Mitera declared in January 2022 that its Peaches & Me and 23Pears at-home reproductive genetic testing kits will be available in all 50 states. The first non-invasive prenatal test (NIPT) that clients may obtain online and have performed at home is Peaches & Me. It can identify the baby's gender and screen for conditions like Down syndrome as early as week 10 of pregnancy. Thus, this is expected to dominate the market over the forecast period.

Carrier Screening Market- Competitive Landscape:

Leading companies in the worldwide Carrier Screening market are stepping up their R&D efforts to diversify their product offerings. Additionally, these market participants use strategic alliances and partnerships that promote growth. The key players operating in the market include Myriad Genetics, Inc, Cepheid, Illumina, Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, Otogenetics, MedGenome, GeneTech and Centogene N.V.

Recent Developments:

In December 2022, a strategic relationship was established between Oxford Nanopore Technologies and Bio-Techne to provide an integrated wet- and dry-lab kit for genotyping 11 genes necessary for carrier screening.

Key features of the study:

  • This proposed research study on Carrier Screening market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Carrier Screening market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Carrier Screening market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Carrier Screening market
  • Impact of COVID-19 on Carrier Screening market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Carrier Screening market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Carrier Screening market, we have also included competitive landscape and key innovator analysis for the Carrier Screening market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Carrier Screening market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Carrier Screening market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARRIER SCREENING MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc
  • Cepheid
  • Illumina
  • Myriad Genetics, Inc
  • F.Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • Otogenetics
  • MedGenome
  • GeneTech
  • Centogene N.V.

GLOBAL CARRIER SCREENING MARKET, BY TYPE

  • Expanded Carrier Screening
  • Targeted Disease Carrier Screening

GLOBAL CARRIER SCREENING MARKET, BY MEDICAL CONDITION

  • Cystic Fibrosis
  • Tay-Sachs
  • Gaucher Disease
  • Sickle Cell Disease
  • Spinal Muscular Atrophy
  • Others

GLOBAL CARRIER SCREENING MARKET, BY TECHNOLOGY

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

GLOBAL CARRIER SCREENING MARKET, BY END USER

  • Hospitals
  • Laboratories
  • Physician Offices & Clinics
  • Others

GLOBAL CARRIER SCREENING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Carrier Screening Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Carrier Screening Market Snippet by Type
    • 2.1.2. Carrier Screening Market Snippet by Medical Condition
    • 2.1.3. Carrier Screening Market Snippet by Technology
    • 2.1.4. Carrier Screening Market Snippet by End User
    • 2.1.5. Carrier Screening Market Snippet by Country
    • 2.1.6. Carrier Screening Market Snippet by Region
  • 2.2. Competitive Insights

3. Carrier Screening Key Market Trends

  • 3.1. Carrier Screening Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Carrier Screening Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Carrier Screening Market Opportunities
  • 3.4. Carrier Screening Market Future Trends

4. Carrier Screening Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Carrier Screening Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Carrier Screening Market Landscape

  • 6.1. Carrier Screening Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Carrier Screening Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Expanded Carrier Screening
    • 7.1.3. Targeted Disease Carrier Screening

8. Carrier Screening Market - By Medical Condition

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Medical Condition, 2022 & 2030 (%)
    • 8.1.2. Cystic Fibrosis
    • 8.1.3. Tay-Sachs
    • 8.1.4. Gaucher Disease
    • 8.1.5. Sickle Cell Disease
    • 8.1.6. Spinal Muscular Atrophy
    • 8.1.7. Others

9. Carrier Screening Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 9.1.2. DNA Sequencing
    • 9.1.3. Polymerase Chain Reaction
    • 9.1.4. Microarrays
    • 9.1.5. Others

10. Carrier Screening Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Laboratories
    • 10.1.4. Physician Offices & Clinics
    • 10.1.5. Others

11. Carrier Screening Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Carrier Screening Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Carrier Screening Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Carrier Screening Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Carrier Screening Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Carrier Screening Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Medical Condition, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Carrier Screening Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc
    • 12.2.2. Cepheid
    • 12.2.3. Illumina
    • 12.2.4. Myriad Genetics, Inc
    • 12.2.5. F.Hoffmann-La Roche Ltd
    • 12.2.6. Laboratory Corporation of America Holdings
    • 12.2.7. Otogenetics
    • 12.2.8. MedGenome
    • 12.2.9. GeneTech
    • 12.2.10. Centogene N.V.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제